1. , . Endocrine system. In , editor, Potter’s Pathology of the Fetus, Infant and Child, second edn. New York: Mosby Elsevier; 2007;1595–605.
2. , . The histological features and human growth hormone content of the pharyngeal pituitary gland in normal and endocrinologically-disturbed patients. Clin. Endocrinol 1973;2:157–73.
3. , , . Hypopituitarism following extirpation of a pharyngeal pituitary. Am. J. Dis. Child. 1977;131:525–8.
4. , , , . Partially reversible hypopituitarism in an adolescent with a Rathke cleft cyst. Clin. Pediatr. Endocrinol. 2012;21:75–80.
5. , , , . Pituitary adenomas in childhood and adolescence. Results of transsphenoidal surgery. J. Neurosurg. 1994;80:209–16.
6. , , , , . Transsphenoidal surgery for pituitary adenomas in children. Neurosurgery 1994;34;207–12.
7. , , . Pediatric pituitary adenoma: A series of 42 patients. J. Clin. Neurosci. 2005;12:124–7.
8. , . Pituitary tumors in childhood. Curr. Opin. Endocrinol. Diabetes Obes. 2012;19:63–7.
9. , . Pituitary adenomas in childhood and adolescence. Pediatr. Endocrinol. Rev. 2013;10:450–9.
10. , , , et al. Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review. Pituitary 2013;17:267.
11. , , et al. Proliferating cell nuclear antigen (PCNA) expression in pituitary adenomas: relationship to the endocrine phenotype of adenoma. Folia Histochem. Cytobiol. 2006;44:37–41.
12. , , , et al. Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J. Neurosurg. 1993;78:753–61.
13. , , , et al. Increased Wingless (Wnt) signaling in pituitary progenitor cells gives rise to pituitary tumors in mice and humans. Proc. Natl. Acad. Sci. USA 2011;108:11482–7.
14. , , . Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1). Minerva Endocrinol. 2013;38:17–28.
15. . MEN 1 and pituitary adenomas. Ann. Endocrinol. (Paris) 2012;73:59–61.
16 , , , , . Prolactin secretion abnormalities in patients with the “syndrome of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas” (Carney complex). J. Clin. Endocrinol. Metabol. 2000;13:373–9.
17. , . Etiology of fibrous dysplasia and McCune- Albright syndrome. Int. J. Oral Maxillofac. Surg. 1999;28:366–71.
18. , , , et al. The role of germline AIP, MEN1, PRKAR1 A, CDKN 1B, CDKN 2C mutations causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes. Clin. Genet. 2010;78:457–63.
19. . The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J. Clin. Endocrinol. Metabol. 2008;93:2390–401.
20. , , , . Pituitary adenoma and concomitant Rathke’s cleft cyst. Acta Neurochir. (Wien) 2007;149:1223–8.
21. , , , et al. Collision lesions of the sella: coexistence of craniopharyngioma with gonadotroph adenoma and of Rathke’s cleft cyst with corticotroph adenoma. Pituitary 2008;11:317–23.
22. , , , . Atypical presentation of pediatric mixed germ cell tumors in the sellar and suprasellar region. Neurol. India 2012;60:90–3.
23. , , , , . Lymphocytic hypophysitis presenting with diabetes insipidus in a 14 year-old girl: case report and review of the literature. Eur. J. Pediatr. 1997;156:684–8.
24. , , , . Hypothalamic hamartoma associated with central precocious puberty and growth hormone deficiency. J. Pediatr. Endocrinol. Metab. 2013;10:1–5.
25. , , , et al. Pallister-Hall syndrome with stenosis of the cricoid cartilage and microphallus without hypopituitarism. Genet. Couns. 2001;12:231–5.
26. , , . Thyroid Hemiagenesis: Report of a Case and Review of Literature. Indian. J. Otolaryngol. Head Neck Surg. 2011;63:198–200.
27. Di George’s or the III-IV pharyngeal pouch syndrome: pathology and a theory of pathogenesis. Perspect. Pediatr. Pathol. 1975;3:173–206.
28. , , . Thyroid C cells in the Di George syndrome. Pediatr. Pathol. 1993;13:463–73.
29. , , , et al. CT and MRI findings of developmental abnormalities and ectopia varieties of the thyroid gland. Diagn. Interv. Radiol. 2012;18:335–43.
30. , , , et al. Surgical management of primary thyroid carcinoma arising in thyroglossal duct cyst: An experience of a single institution in Serbia. Endocr. J. 2012;59:517–22.
31. , , . et al. First branchial cleft anomalies: A study of 39 cases and a review of the literature. Arch. Otolaryngol. Head Neck Surg. 1998;124:291–5.
32. , , , , . Revisiting imaging features and the embryologic basis of third and fourth branchial anomalies. Am. J. Neuroradiol. 2010;31:755–60.
33. , . Immunologic endocrine disorders. J. Allergy Clin. Immunol. 2010;125(Suppl 2):S226–37.
34. , , , et al. Clinical relationship between Hashimoto thyroiditis and papillary thyroid cancer. Acta Oncol. 2011;50:1228–34.
35. , , , et al. Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases. Thyroid 2011;21:37–41.
36. , , et al. Thyroid cancer in patients with Grave’s Disease. J. Chir. (Paris) 2008; 145:244–6.
37. , , , , et al. Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease. Eur. J. Endocrinol. 2010;162:763–70.
38. , , , . Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases. Surgery 2009;146:1099–104.
39. , , . The pineal, pituitary, parathyroid, thyroid and adrenal glands. In: , , editors, Pediatric Pathology, second edn. Philadelphia: Lippincott Williams & Wilkins; 2001;1028–40.
40. , . Genetics of congenital hypothyroidism. J. Med. Genet. 2005;42:379–89.
41. . The pathology of dyshormonogenetic goiter. J. Pathol. 1969;99:251–64.
42. , , . Thyroid cancer in children: A 20-year study at a Romanian oncology institute. Endocr. J. 2012;59:489–96.
43. , , , . The clinical course of Hashimoto’s thyroiditis in children and adolescents: 6 years longitudinal follow-up. J. Pediatr. Endocrinol. Metab. 2001;14:177–84.
44. , , , et al. Predictive factors of malignancy in pediatric thyroid nodules. Surgery 2011;150:1228–33.
45. , , , et al. Sensitivity of fine-needle biopsy in detecting pediatric differentiated thyroid carcinoma. Pediatr. Blood Cancer 2012;59:233–7.
46. , , , et al. Papillary carcinoma of the thyroid gland of childhood and adolescence: Morphologic subtypes, biologic behavior and prognosis: A clinicopathologic study of 42 sporadic cases treated at a single institution during a 30-year period. Am. J. Surg. Pathol. 2006;30:1420–61.
47. , , , . Genetic analysis of a papillary thyroid carcinoma in a patient with MEN1. Ann. Surg. Oncol. 2001;8:342–6.
48. . Familial non-medullary thyroid carcinoma: An update. Endocr. Pathol. 2008;19:226–40.
49. , , , , . Follicular thyroid cancer in children and adolescents: clinicopathologic features, long-term survival, and risk factors for recurrence. Endocr. J. 2013;60:629–35.
50. , , . WHO Tumors of Endocrine Organs. World Health Organization Classification of Tumors , editor. Lyon: IARC Press, 2004.
51. , , . Thyroid disease associated with Cowden syndrome: A meta-analysis. Head Neck 2013;35:1189–94.
52. , , , . Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: An update. J. Clin. Endocrinol. Metab. 2013;98:3149–64.
53. , . Precursor lesions of endocrine system neoplasms. Pathology 2013;45:316–30.
54. , , . Pathological and clinical findings in a series of 67 cases of medullary carcinoma of the thyroid. J. Clin. Pathol. 1966;19:103–13.
55. , , , et al. Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens. Am. J. Clin. Pathol. 1991;95:300–8.
56. , , et al. Surgical approach to medullary thyroid carcinoma associated with multiple endocrine neoplasia type 2. Clinics (Sao Paulo) 2012; 67 Suppl 1:149–54.
57. , . Parathyroid glands. In , editor, Histology for Pathologists, second edn. Philadelphia: Lippincott-Raven 1997:1093–105.
58. . The anatomic basis of parathyroid surgery. Ann. Surg. 1976;183:271–75.
59. , , . Ectopic parathyroid tissue within the vagus nerve. Arch. Pathol. Lab. Med. 1988;112:304–6.
60. , , , , . Parathyroid detection in secondary hyperparathyroidism with 123I/99m Tc-sestamibi subtraction single photon emission computed tomography. J. Clin. Endocrinol. Metabol. 1998;83:3867–71.
61. , . Thyroid and parathyroid glands in the vaginal wall: report of a case. Am. J. Clin. Pathol. 1973;59:503–7.
62. , , . Parathyroid hyperplasia and parathyromatosis. Lancet 1977;1:549 (letter).
63. , , , . Hoxa3 and pax1 regulate epithelial cell death and proliferation during thymus and parathyroid organogenesis. Dev. Biol. 2001;236:316–29.
64. , , , et al. Patterning of the third pharyngeal pouch into the thymus/parathyroid by Six and Eya 1. Dev. Biol. 2006;293:499–512.
65. . Branchio-oto-renal syndrome. J. Nephrol. 2003;16:603–5.
66. , . Ultrastructural study of acid phosphatase activity in normal, adenomatous and hyperplastic (chief cell type) human parathyroid glands. Am. J. Pathol. 1974;77:493–506.
67. . Atlas of Tumor Pathology: Tumors of the Parathyroid Gland 3rd Series. Washington DC: Armed Forces Institute of Pathology,1991.
68. , , , . Intrauterine hyperparathyroidism secondary to maternal hypoparathyroidism. Pediatrics 1968;42:606–8.
69 , , , et al. Parathyroid hormone and neonatal calcium homeostasis: evidence for secondary hyperparathyroidism in the Asian neonate. Metabolism 1986;35:803–6.
70. , , , . Dynamic changes in serum osteocalcin levels in the perinatal period. Nihon Naibuni Gakkai Zasshi 1989;65:1116–22.
71. , , , et al. Ethnic differences in umbilical cord blood vitamin D and parathyroid hormone – South Asians compared to Whites born in the UK. J. Matern. Fetal Neonatal Med. 2010;23:1315–17.
72. , , . Metabolic bone disease of prematurity and secondary hyperparathyroidism. J. Paediatr. Child. Health 2011;47:550–3.
73. , . Large solitary cysts of the parathyroid gland. Br. J. Surg. 1956;44:23–4.
74. , , , , . Functional parathyroid cyst and hypocalciuric hypercalcemia. Ear Nose Throat J. 1993:72:142–4.
75. , , , , . Thoracoscopic resection of a giant mediastinal parathyroid cyst. Gen. Thorac. Cardiovasc. Surg. 2013 (Epub ahead of print).
76. , , , . Mixed multilocular ectopic thymic cyst with parathyroid element presenting as neck mass. Ann. Acad. Med. Singapore 2012;41:271–2.
77. , , . Parathyroid adenoma, parathyroid crisis, and acute pancreatitis in an adolescent. J. Pediat. 1973;83:273–5.
78. , , . Parathyroid carcinoma in a child: unusual presentation with seizures. J. Pediatr. Surg. 1984;19:194–200.
79. , , , , Parathyroid carcinoma in a child. J. Pediatr. Surg. 1999;34:606–8.
80. , , . Parathyroid carcinoma in a child: An unusual case of an ectopically located malignant parathyroid gland with tumor invading the thymus. J. Pediatr. Surg. 2009;44:1649–52.
81. , , , . Intrathyroidal parathyroid carcinoma in a pediatric patient. Pediatr. Surg. Int. 2011;27:1361–5.
82. , , , et al. A 10 year retrospective study of primary hyperparathyroidism in children. Exp. Clin. Endocrinol. Diabetes 2012;120:229–33.
83. , , , , . The parathyroid glands. In , , editors, Functional Endocrine Pathology. Boston: Blackwell Scientific, 1990:375–95.
84. , , , , . Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma. Br. J. Surg. 2007;94(5):566–70.
85. , , , . Primary hyperparathyroidism with low intact PTH levels in a 14- year-old girl. J. Clin. Endocrinol. Metabol. 2011;96:2325–9.
86. , , . Chronic kidney disease mineral and bone disorder in children. Pediatr. Nephrol. 2008;23:195–207.
87. . Bone disease in pediatric chronic kidney disease. Pediatr. Nephrol. 2013;28:569–76.
88. , , , . Successful use of biphosphonate and calcimimetic in neonatal severe primary hyperparathyroidism. Pediatrics 2012;129:812–16.
89. , Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism. Best. Pract. Res. Clin. Endocrinol. Metab. 2013;27:359–71.
90. , , . Multiple endocrine neoplasia type 1. In , , , , , , editors, GeneReviews™ (Internet). Seattle, WA: University of Washington, Seattle, 1993–2013.
91. , , . Variable clinical expression in patients with a germline MEN1 disease gene mutation: clues to a genotype –phenotype correlation. Clinics (Sao Paulo) 2012;67:(S1)49–56.
92. , , , et al. Multiple endocrine neoplasia type 2. Orphanet. J. Rare Dis. 2006;2:1–38.
93. , , , et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997;276:404–407.
94. , , . Multiple endocrine neoplasia type 1: A chromatin writer’s block. J. Intern. Med. 2009;266(1):53–9.
95. , , , et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J. Clin. Endocrinol. Metab. 2012;97:2990–3011.
96. , , , . Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2. Clinics (Sao Paulo) 2012;67 Suppl 1:77–84.
97. , , , et al. Medullary thyroid carcinoma identified within the first year of life in children with hereditary multiple endocrine neoplasia type 2A (codon 634) and 2B. Eur. J. Endocrinol. 2009;160:807–13.
98. , , . Rare syndromes. Clin. Dermatol. 2006;24:299–316.
99. , , , . Adrenal ganglioneuromas in children with multiple endocrine neoplasia type 2: A report of two cases. J. Clin. Endocrinol. Metab. 2005;90:4383–7.
100. , . Multiple endocrine neoplasia type 2B–genetic basis and clinical expression. Surg. Oncol. 2000;9:111–8.
101. , . Genotype-phenotype correlation in multiple endocrine neoplasia type 2. Clinics (Sao Paulo) 2012;67 Suppl 1:69–75.
102. . The Borderland of Embryology and Pathology. London: Butterworths, 1958:326–9.
103. . Ectopic adrenal cortex in neonatal liver. Histopathology 1980;4;669–72.
104. , . Mediastinal foregut cyst containing an intramural adrenal cortical rest: A case report and review of supradiaphragmatic adrenal rests. Pediatr. Pathol. 1993;13:401–7.
105. , , , et al. Testicular rest tumors (TART) in adult men with classic congenital adrenal hyperplasia (CAH). Urologe A 2008:1596–7,1599–602.
106. , , , , . Testicular adrenal rest tumors in congenital adrenal hyperplasia. Best Pract. Res. Clin. Endocrinol. Metab. 2009;23:209–20.
107. , , , , . Testicular adrenal rest tumors in boys, adolescents and adult men with congenital adrenal hyperplasia may be associated with the CYP21A2 mutation. Int. J. Androl. 2010;33:521–7.
108. . Complex familiale avec hernie ombilicale et macroglossie –un sybndrome nouveau. J. Genet. Hum. 1964;13:223–32.
109. . Macroglossia, omphalocele, adrenal cytomegaly, gigantism and hyperplastic visceromegaly. Birth Defects Orig. Artic. Series 1969;5:188–96.
110. , , , et al. Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome. Eur. J. Hum. Genet. 2005;13:1025–32.
111. , , . Adrenal cytomegaly. Virchows Arch. A 1972;355:105–22.
112. , . Intrauterine rubella infection. Perspect. Pediatr. Pathol. 1973;1:313–38.
113. , , , et al. Non immunologic hydrops fetalis; a clinicopathologic study of 50 autopsy cases. Pediatr. Pathol. 1987;7:19–30.
114. , , , . Flow cytometry of fetal adrenal glands with adrenocortical cytomegaly. Pediatr. Pathol. 1989;9:551–8.
115. , , , . Adrenal cytomegaly: quantitative assessment by image analysis. Pediatr. Pathol. 1991;11:521–36.
116. , . Adrenal cytomegaly associated with diaphragmatic hernia: report of a case. Malays. J. Pathol. 1996;18:121–123.
117. , , et al. Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J. Clin. Endocrinol. Metab. 1992;75:76–81.
118. , , , , . Cushing’s syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome. J. Pediatr. 1999;134:789–92.
119. , , , et al. Cytogenetic and microsatellite alterations in tumors from patients with the syndrome of myxomas, spotty skin pigmentation, and endocrine overactivity (Carney complex). J. Clin. Endocrinol. Metab. 1996;81:3607–14.
120. , , . Cystic neuroblastoma. J. Pediatr. Surg. 1992;27:1320–1.
121. , , , et al. Bilateral absence of adrenal glands: A case series that expands the spectrum of associations and highlights the difficulties in prenatal diagnosis. Fetal Pediatr. Pathol. 2011;30:137–43.
122. , , , . Adrenocortical neoplasm’s in children: radiologic-pathologic correlation. Radiographics 1999;19:989–1008.
123. , , et al. Clinical and outcome characteristics of children with adrenocortical tumors: A report from the International Pediatric Adrenocortical Tumor Registry. J. Clin. Oncol. 2004;22:838–45.
124. , , , et al. Clinical characteristics of adrenocortical tumors in children. J. Pediatr. Endocrinol. Metab. 2011;24:535–41.
125. , , , et al. Androgen-producing bilateral large cortical adrenal adenomas associated with polycystic ovaries in a young female. Postgrad. Med. J. 1992;68:219–22.
126. , , , . Adrenal cortical tumors in childhood. Pediatr. Hematol. Oncol. 1998;15:527–32.
127. , , . Adrenocortical tumors: recent advances in basic concepts and clinical management. Ann. Intern. Med. 1999;130:759–71.
128. , , . Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma. Endocr. Pathol. 2006;17:345–54.
129. , , , et al. The prognostic value of two different histopathological scoring systems for adrenocortical carcinomas. Histopathology 2007;51:239–45.
130. , . The Weiss system for evaluating the adrenocortical neoplasms: 25years later. Hum. Pathol. 2009;40:757–68.
131. , , , et al. The Weiss score and beyond – histopathology for adrenocortical carcinoma. Hum. Cancer 2011;2:333–49.
132. , . Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults. Mol. Cell. Endocrinol. 2012;351:52–7.
133. , . Adrenocortical neoplasia; evolving concepts in tumorigenesis with an emphasis on adrenal cortical carcinoma variants. Virchows Arch. 2012;460:9–18.
134. , , , et al. Comparison of adrenal cortical tumors in children and adults. Cancer 1986;57:2235–7.
135. , , , . Adrenal cortical neoplasms in the pediatric and adolescent age group. Clinicopathologic study of 30 cases with emphasis on epidemiological and prognostic factors. Pathol. Annu. 1992;27:1–53.
136. , Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J. Natl. Cancer Inst. 1969;43:1365–73.
137. . Association of adrenocortical carcinoma with familial cancer susceptibility syndromes. Mol. Cell. Endocrinol. 2012;351:66–70.
138. , , , . Biology, clinical characteristics and management of adrenocortical tumors in children. Pediatr. Blood Cancer 2005;45:265–73.
139. , , , , , et al. Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors. Genes Chromosomes Cancer 2012;51:949–60.
140. , , , et al. Identification of novel genetic variants in phosphodiesterase (PDE8B), a camp-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with tumors. Clin. Endocrinol. (Oxf) 2012;77:195–9.
141. , , , et al. Dysregulation of microRNAs in adrenocortical tumors. Mol. Cell. Endocrinol. 2012;351:118–28.
142. . The adrenal gland. In , , , editors, Principles and Practice of Surgical Pathology and Cytopathology, third edn. New York: Churchill-Livingstone, 1997:2751–99.
143. , , , et al. Adrenal medullary hyperplasia. A morphometric analysis in patients with familial medullary thyroid carcinoma. Am. J. Pathol. 1976;83:177–96.
144. , . Familial pheochromocytoma. Hormones (Athens) 2009;8:29–38.
145. , , , , . Cushing syndrome in an infant due to cortisol secreting adrenal pheochromocytoma: A rare association. J. Pediatr. Endocrinol. Metab. 2010;23:621–5.
146. , , , et al. Genetic testing in pheochromocytoma or functional paraganglioma. J. Clin. Oncol. 2005;23:8812–18.
147. , , . Adrenal medullary disease in multiple endocrine neoplasia 2. Am. J. Clin. Pathol. 1976;66:279–90.
148. . Adrenal and other paraganglia. In Rosai and Ackerman’s Surgical Pathology, tenth edn. Oxford: Elsevier Mosby; 2011;1076–8.
149. . The adrenal medulla. In , editor, Functional Pathology of the Adrenal Gland. Baltimore: Williams and Wilkins; 1969;219–34.
150. , . Oncologic aspects of pheochromocytoma: the importance of follow-up. Surgery 1984;96:1061–6.
151. , , , et al. Terminology and morphologic criteria of neuroblastic tumors: Recommendation by the International Neuroblastoma Pathology Committee. Cancer 1999;86:349–93.
152. . Peripheral neuroblastic tumors: pathologic classification based on recommendations of International Neuro blastoma Pathology Committee (modification of Shimada classification). Pediatr. Dev. Pathol. 2000;3:184–99.
153. , , , et al. Neonatal cancer. Lancet Oncol. 2013;14(13):e609–20.
154. , . The natural history of neuroblastic cells in the fetal adrenal glands. Am. J. Pathol. 1974;76:225–44.
155. , . In situ neuroblastomas: A contribution to the natural history of neural crest Tumors. Am. J. Pathol. 1963;43:1089–104.
156. , , . Neuroblastoma: A roentgenologic and pathologic study. Am. J. Rontgenol. Radium Ther. Nucl. Med. 1957;78:420–36.
157. , , . A proposed staging for children with neuroblastoma. Cancer 1971;27:374–8.
158. , , , et al. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J. Clin. Oncol. 1993;11:1466–77.
159. , . Stage IV S neuroblastoma: A clinical, histological and biological analysis of 45 cases. Hum. Pathol. 1996;27:1135–8.
160. , , , et al. Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: A report from the Children’s Oncology Group. J. Clin. Oncol. 2008;26:913–18.
161. , , et al. Cytogenetic features of human neuroblastomas and cell lines. Cancer Res. 1981;41:4678–86.
162. , , , , . Abnormalities of chromosome 1p in human neuroblastoma Tumors and cell lines. Cancer Genet. Cytogenet. 1982;7:33–42.
163. , , , , . Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984;224(4653):1121–4.
164. , , , et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med. 1985;313:1111–16.
165. , , , et al. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N. Engl. J. Med. 1993;328:847–54.
166. , , , et al. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N. Engl. J. Med. 1991;325:1608–14.
167. , , , et al. Hyperdiploid plus non amplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: A Pediatric Oncology Group study. J. Clin. Oncol. 2005;23(27):6466–73.
168. , , , et al. Histopathology and MYCN status in peripheral neuroblastic tumors: A report from the Children’s Cancer Group. Cancer 2001;92:2699–708.
169. , , , et al. Survivin mRNA levels are associated with biology of disease and patient survival in neuroblastoma: A report from the Children’s Cancer Group. J. Pediatr. Hematol. Oncol. 2006;28:412–17.
170. , , , et al. Repp86 expression and outcome in patients with neuroblastoma. J. Clin. Oncol. 2003;21:1810–18.
171. , , , et al. The tumor-associated antigen PRAME is universally expressed in high stage neuroblastoma and associated with poor outcome. Clin. Cancer Res. 2004;10:4307–13.
172. , , , et al. TrkA expression in peripheral neuroblastic tumors: prognosis, significance and biological relevance. Cancer 2004;101;1873–81.
173. , , , et al. CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiations programs in neuroblastoma cells. Cancer Res. 2011;15:3142–51.
174. , , , et al. Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma. Cancer Res. 2004;64:6883–91.
175. , , , et al. The International Neruoblastoma Risk Group (INRG) Classification System: An INRG task force report. J. Clin. Oncol. 2009; 27:289–97.
176. , , , et al. Epidemiological evidence for a common mechanism for neuroblastoma and differentiated thyroid tumor. Br. J. Cancer 1992;65:425–8.
177. , , , . Asymptomatic myelolipoma of the adrenal. Pediatr. Radiol. 1992;22:465–6.
178. , , . Adrenal myelolipoma in a child. Pediatr. Surg. Int. 2005;21:500–2.
179. , , , , . A unique case of synchronous functional adrenocortical adenoma and myelolipoma within the ectopic adrenal cortex in a child with Beckwith-Wiedemann Syndrome. Pathol. Res. Pract. 2012;208:189–94.
180. , , et al. Generalized myelolipoma. Arch. Iran. Med. 2006;9:274–6.
181. , . The endocrine pancreas of the neonate and infant. Perspect. Pediatr. Pathol. 1982:7:137–65.
182. , , . Quantitave morphology of B, A, D, and PP cells in infants of diabetic mothers. Diabetes 1981;30:271–4.
183. , , et al. Nesidioblastosis and mixed hamartoma of the liver in Beckwith-Wiedemann syndrome: case study including analysis of H19 methylation and insulin-like growth factor 2 genotyping and imprinting. Pediatr. Dev. Pathol. 2001;4:381–90.
184. , , , . The Perlman syndrome: Familial renal dysplasia with Wilms tumor, fetal gigantism and multiple congenital anomalies. Am. J. Genet. A 2013;161:2691–6.
185. , , , . Cerebro-hepato-renal syndrome of Zellweger. Two patients with islet cell hyperplasia, hypoglycemia, and thymic anomalies, and comments on iron metabolism. Am. J. Dis. Child. 1972;124:840–4.
186. , , , . Tyrosinosis. A study of 6 cases. Arch. Dis. Child. 1966;41:238–49.
187. , , et al. Costello syndrome with pancreatic cell hyperplasia. Am. J. Genet. A 2004;130A:402–5.
188. , , . Neonatal hemochromatosis- a report of an autopsy case. J. Korean Med. Sci. 1999;6:267–72.
189. . Nesidioblastoma, islet tumor of pancreas. Am. J. Pathol. 1938;14:125–34.
190. , , . Beta cell nesidioblastosis in idiopathic hypoglycemia of infancy. J. Pediatr. 1971;79:226–31.
191. , , et al. Practical management of hyperinsulinism in infancy. Arch. Dis. Child. Fetal Neonatal Ed. 2000;82:F98–107.
192. , , , , . Hyperinsulinism in Infancy: From basic science to clinical disease. Physiol. Rev. 2004;84:239–75.
193. , , , et al. Partial or near total pancreatectomy for persistent neonatal hyperinsulinaemic hypoglycaemia: the pathologist’s role. Histopathology 1998; 32:15–19.
194. , , , , . Histologic findings in persistent hyperinsulinemic hypoglycemia of infancy: Australian experience. Pediatr. Devel. Pathol. 2000;3:532–47.
195. , , et al. Morphological mosaicism of the pancreatic islets: A novel anatomopathological form of persistent hyperinsulinemic hypoglycemia of infancy. J. Endocrinol. Metab. 2011;96:3785–93.
196. , , et al. 18F-fluoro-L-DOPA PET-CT imaging combined with genetic analysis for optimal classification and treatment in a child with severe congenital hyperinsulinism. Ann. Pediatr. 2008;68(5):481–5.
197. , , , et al. Intraoperative sonography: A technique for localizing focal forms of congenital hyperinsulinism in the pancreas. Ultraschall. Med. 2011,32:74–80.
198. , et al. Congenital hyperinsulinism: current trends in diagnosis and therapy. Orphanet. J. Rare Dis. 2011;6:63.
, , , et al
. Molecular mechanisms of neonatal hyperinsulinism
. Horm. Res. 2006